Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
CVS Caremark, Express Scripts ... Association did not respond to requests for comment. CVS Health, UnitedHealth Group and Cigna share prices dipped midday after the FTC released its report ...
The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
We recently published a list of 10 Companies Reflect Market Decline. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against other companies ...
The City of Greensboro, North Carolina, which provides public safety, emergency, and health services to over 300,000 residents and spends millions annually on insulin medications, filed a lawsuit last ...